National Coalition On Health Care Spearheads Rx-Price Sunshine Push; PhRMA Resists

The National Coalition on Health Care is spearheading an effort to get drug makers to disclose how much they spend inventing drugs and their rationale for drug prices. The broad-based stakeholder group is trying to set up a meeting with the drug industry and other stakeholders to figure out how the transparency measures would work, but a Pharmaceutical Research and Manufacturers of America official indicated that the drug trade group is not interest in negotiating. In May, America's Health Insurance...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.